EP3313356A1

EP3313356A1 - Alkane-diol-containing sun protection means with starting materials for forming 4-(tert-butyl)-4'-methoxydibenzoylmethane

Info

Publication number: EP3313356A1
Application number: EP16726900.0A
Authority: EP
Inventors: Charlotte WILLE; Andreas Bleckmann; Torsten Schläger
Original assignee: Beiersdorf AG
Current assignee: Beiersdorf AG
Priority date: 2015-06-25
Filing date: 2016-06-06
Publication date: 2018-05-02
Also published as: WO2016206963A1; DE102015211793A1

Abstract

The invention relates to a cosmetic composition containing a) one or more alkane diols selected from the group of compounds 1,2-pentandiol, 1,2-hexandiol, 1,2-octandiol, 1,2-decandiol, 2-methyl-1,3-propandiol and b) compound (1).

Description

description

Alkandiol-containing sunscreens with starting material for the formation of 4- (tert-butyl) -

4'-methoxydibenzoylmethane

The present invention relates to a cosmetic preparation containing defined alkanediols and a precursor for 4- (tert-butyl) -4'-methoxydibenzoylmethane.

The trend away from sophisticated paleness to "healthy, sporty brown skin" has been unbroken for years, and people are exposing their skin to sunlight, as it causes pigmentation in the sense of melanin formation, which has ultraviolet radiation from sunlight In addition to the acute injury (sunburn), long-term damage such as an increased risk of developing skin cancer due to excessive exposure to light from the UVB range (wavelength: 280-320 nm) occurs UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the

Connective tissue. This leads to numerous phototoxic and photoallergic reactions and leads to premature skin aging. To protect the skin, therefore, a number of sunscreen filter substances has been developed which can be used in cosmetic preparations. These UVA and UVB filters are summarized in most industrialized countries in the form of positive lists such as Appendix 7 of the Cosmetics Regulation. However, the variety of commercially available sunscreens must not obscure the fact that these prior art formulations have a number of disadvantages.

In sunscreens, 4- (tert-butyl) -4'-methoxydibenzoylmethane is usually used as the UV-A filter. However, this UV filter has the known disadvantage, not alone To be photostable, but slowly decompose especially under UV-B radiation.

If no further stabilizers (for example octocrylene) are added to the preparation, this decomposition process leads to a lower durability of the product as a whole and in particular to a decreasing UV-A protection over time.

Furthermore, 4- (tert-butyl) -4'-methoxydibenzoylmethane has the likewise known disadvantage of not being particularly soluble in cosmetic preparations, but rather of crystallizing out of the preparation relatively quickly. This also affects the durability and shelf life of the sunscreen, in particular their storage and temperature stability.

A relatively new approach to solving these problems of 4- (tert-butyl) -4'-methoxydibenzoylmethane in cosmetic preparations is to use precursors of 4- (tert-butyl) -4'-methoxydibenzoylmethane to be used in the preparations. These are then used, since they transform under sunlight into the 4- (tert-butyl) -4'-methoxydibenzoylmethane, as the starting material for a resulting in the application of UV-A protection. such

Starting materials (precursors) are disclosed, for example, in WO2006 / 100225.

However, a disadvantage of the prior art is the fact that the precursors only relatively slowly and incompletely convert into the 4- (tert-butyl) -4'-methoxydibenzoylmethane to be formed. This is especially true for the following conversion reaction:

Compound 1 4- (tert-butyl) -4'-methoxydibenzoylmethane

It was therefore the object of the present invention to develop a cosmetic sunscreen containing compound 1, in which the photochemical conversion reaction is faster and more complete than in the formulations of the prior art.

The object is surprisingly achieved by a cosmetic preparation comprising a) one or more alkanediols selected from the group of compounds 1, 2-pentanediol, 1, 2

Hexanediol, 1, 2-octanediol, 1, 2-decanediol, 2-methyl-1, 3-propanediol and

b)

Connection 1

The preparations according to the invention are distinguished by a significantly faster and more complete conversion of the precursor under UV light into 4- (tert-butyl) -4'-methoxydibenzoylmethane than is the case in the preparations of the prior art.

Preparations as known from WO2006 / 060886 generally contain

Propylene glycol and / or butylene glycol. Compared to these alkanediols is the

Conversion rate under comparable conditions in the presence of the alkanediols according to the invention significantly larger.

Moreover, the preparations according to the invention have the surprising advantage that they have a significantly lower yellowing before application (ie before the skin creamed with the preparation is exposed to sunlight) than is the case with preparations which contain an equivalent amount of (tert-butyl) -4'-methoxydibenzoylmethane included.

In addition, the preparations according to the invention lead to a significantly reduced textile staining (yellowing), as is the case with preparations which contain an equivalent amount of 4- (tert-butyl) -4'-methoxydibenzoylmethane, if the preparations before, during or advised to come into contact with textiles after use on the skin.

Although the prior art knows WO2006 / 100225, EP 2488537, EP231 1844,

WO2011 / 045389, US 2012/0230932, US 8945522, DE 10201 11 15285, WO 2013/045016, EP 2568953, FR 2857663, EP 1648849 and US 2013/0058879, but these documents could not point the way to the present invention.

It is advantageous according to the invention if the cosmetic preparation contains compound 1 in a concentration of 0.1 to 6% by weight, based on the total weight of the preparation.

It is preferred according to the invention if the cosmetic preparation contains compound 1 in a concentration of 1 to 4.75% by weight, based on the total weight of the preparation. Advantageously according to the invention, the total concentration of the inventive

Alkanediols (1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol, 2-methyl-1, 3-propanediol) in the preparation of 0.1 to 5% by weight, based on the total weight of the preparation (ie if the preparation contains only one alkanediol, this concentration corresponds to the

Single concentration of this alkanediol).

According to the invention, the total concentration of the alkanediols (1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, 2-methyl-1,3-propanediol) in the preparation of 0 is preferably 2 to 4% by weight, based on the total weight of the preparation (ie if the preparation contains only one alkanediol, this concentration corresponds to

Single concentration of this alkanediol).

According to the invention, the preparation according to the invention advantageously contains ethanol.

Embodiments of the present invention that are advantageous according to the invention are further characterized in that the preparation contains ethanol in a concentration of 0.1 to 99% by weight, based on the total weight of the preparation. It is inventively preferred if the cosmetic preparation ethanol in a

Concentration of 2 to 60% by weight, based on the total weight of the preparation contains.

It is also advantageous for the purposes of the present invention if the preparation contains C 12 -C 15 -alkyl benzoate.

In such a case, the embodiments according to the invention are characterized in that the preparation contains C12-C15 alkyl benzoate in a concentration of 1 to 20% by weight, based on the total weight of the preparation. It is also advantageous according to the invention if the preparation contains one or more dialkyl adipates. Preferred according to the invention are the dialkyl adipates dimethyl adipate,

Diethyl adipate, dipropyl adipate, diisopropyl adipate, diisobutyl adipate, di-n-butyl adipate, di-2-ethylhexyl adipate and dicyclohexyl adipate. Especially preferred according to the invention is the dialkyl adipate di-n-butyl adipate. Advantageously in accordance with the invention, the total concentration of dialkyl adipates in the

Preparation of from 0.5 to 3% by weight, based on the total weight of the preparation (i.e., if the preparation contains only one dialkyl adipate, this concentration corresponds to

Single concentration of this dialkyl adipate).

According to embodiments advantageous embodiments are characterized in that the

Preparation contains one or more dialkyl carbonates. In this case, these dialkyl adipates are preferably selected according to the invention from the group of compounds dicaprylyl carbonate dimethyl carbonate. Diethyl carbonate. Diisopropyl. Di-n-butyl carbonate.

Particularly preferred according to the invention are the dialkyl carbonates diisopropyl carbonate and di-n-butyl carbonate.

Advantageously in accordance with the invention, the total concentration of dialkyl carbonates in the

Preparation of from 1 to 20% by weight, based on the total weight of the preparation (i.e., if the preparation contains only one dialkyl carbonate, this concentration corresponds to

Single concentration of this dialkyl carbonate).

In addition, the preparation of the invention may contain other lipophilic components, for example natural or synthetic oils, fats, waxes, as are commonly used in cosmetics.

Embodiments of the present invention which are advantageous according to the invention are further characterized in that the preparation comprises one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha

Glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, ß-alanine, panthenol, magnolol, honokiol, tocopheryl acetate,

dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.

In addition, it is advantageous according to the invention if the preparation contains phenoxyethanol and / or ethylhexylglycerol. According to the invention, the total concentration of these substances in the preparation is advantageously from 0.1 to 1% by weight, based on the total weight of the preparation (ie if the preparation contains only phenoxyethanol or ethylhexylglycerol, this concentration corresponds to the individual concentration of this substance).

Embodiments of the present invention that are particularly advantageous according to the invention are characterized in that the preparation contains one or more UV filters which are selected from the group of the compounds 2-phenylbenzimidazole-5-sulphonic acid and / or salts thereof; Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts; 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol ; 3- (4-methylbenzylidene) camphor; 3-benzylidene camphor; ethylhexyl salicylate; Terephthalidendicamphersulfonsäure; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester; 4

(Dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 4-methoxycinnamic acid (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; homomenthyl; 2-ethylhexyl 2-hydroxybenzoate;

dimethicodiethylbenzalmalonate; 3- (4- (2,2-ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; 4- (tert-butyl) -4'-methoxydibenzoylmethane; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate; Dioctylbutylamidotriazone (INCI: diethylhexylbutamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS Nos 288254-16-0); 2,4-Bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) ; 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino] (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4,6-tribiphenyl-4-yl-1,3,5-triazine It is inventively preferred if the preparation no 3- (4-methylbenzylidene) - camphor, 2-hydroxy-4-methoxybenzophenone (INCI: oxybenzone) and ethylhexyl-2-cyano-3,3- contains di-phenyl acrylate (INCI: Octocrylen), so is free of these ingredients.

It is preferred according to the invention if the preparation according to the invention contains 2-phenylbenzimidazole-5-sulfonic acid salts. In such a case, it is preferred according to the invention if the preparation contains 2-phenylbenzimidazole-5-sulfonic acid salts in a concentration of 1 to 4% by weight, based on the total weight of the preparation.

The use of sodium or potassium salts according to the invention is advantageous.

Preference is also the use of 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylates). Contains the preparation as salicylate 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylates), it is according to the invention advantageous to use this in a concentration of 3 to 5% by weight, based on the total weight of the preparation.

Contains the preparation as salicylate 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI:

Homosalates), it is according to the invention advantageous to use this in a concentration of 3 to 10% by weight, based on the total weight of the preparation.

If the preparation contains both salicylates, it is advantageous according to the invention 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylate) in a concentration of 2 to 5% by weight and 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI: homosalates) in a concentration of 2 to 10% by weight, based in each case on the total weight of the preparation.

Embodiments of the present invention that are advantageous according to the invention are characterized in that the preparation according to the invention comprises 2,4,6-tris [anilino (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine ( INCI: ethylhexyl triazone).

According to the invention, it is advantageous if the preparation according to the invention comprises 2,4,6-tris [anilino- (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone ) in an amount of 2 to 5% by weight, based on the total weight of the preparation.

It is advantageous for the purposes of the present invention, when the preparation of the invention 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3rd , 5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines). In such a case, it is inventively advantageous if the inventive

Preparation 2,4-Bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines ) in an amount of 2 to 5% by weight, based on the total weight of the preparation.

It is advantageous according to the invention if the preparation is in the form of an emulsion. It is preferred according to the invention if the preparation is in the form of an O / W emulsion.

If the preparation according to the invention is in the form of an emulsion, the embodiments which are advantageous according to the invention are characterized in that the preparation contains one or more emulsifiers selected from the group of compounds

Glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methyl glycose distearate, sodium cetearyl sulfate, sodium staroyl glutamate, polyglyceryl stearate, cetearyl alcohol, cetearyl sulfosuccinate, potassium cetyl phosphate.

According to the invention, the total concentration of these emulsifiers in the preparation is from 0.1 to 10% by weight, based on the total weight of the preparation (ie if the preparation contains only one emulsifier, this concentration corresponds to

Individual concentration of this emulsifier).

The aqueous phase of the preparations according to the invention may advantageously contain customary cosmetic auxiliaries, such as, for example, isopropanol or polyols of low C number and their ethers, preferably propylene glycol, glycerol, electrolytes, self-tanning agents and in particular one or more thickening agents which can be advantageously selected from the group Silica, aluminum silicates, polysaccharides or their derivatives, for. Hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, particularly advantageously from the group of the polyacrylates, preferably a polyacrylate from the group of the so-called carbopols,

for example, Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination. Further thickeners which are advantageous according to the invention are those having the INCI name Acrylates / C10-30 alkyl acrylate crosspolymer (for example Pemulen TR 1, Pemulen TR 2, Carbopol 1328 from NOVEON) and Aristoflex AVC (INCI: ammonium acryloyldimethyltaurate / VP copolymer).

It is preferred according to the invention, when the preparation contains xanthan gum, crosslinked acrylate / C10-C30 alkyl acrylate polymer and / or vinylpyrrolidone / hexadecene copolymer. A content of glycerol of at least 5% by weight, based on the total weight of the preparation, is particularly advantageous according to the invention.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation is free of parabens, methylisothiazolinone,

Chloromethylisothiazolinone and DMDM hydantoin.

It is also advantageous for the purposes of the present invention, when the inventive

Preparation of one or more perfume substances selected from the group of the compounds limonene, citral, linalool, alpha-isomethylionone, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl 1-pentanol, 7-acetyl-1,1,1,4,4,4,6-hexamethyltetralin, adipic diester, alpha-amylcinnamaldehyde, alpha-methylionone, amyl C, butylphenylmethylpropionalcinnamal, amylsalicylate, amylcinnamylalcohol, anisalcohol, benzoin, benzylalcohol, benzylbenzoate, benzylcinnamate , Benzylsalicylate, bergamot oil, bitter orange oil, butylphenylmethylpropioal, cardamom oil, cedrol, cinnamal, cinnamyl alcohol,

Citronellylmethyl crotonate, citron oil, coumarin, diethyl succinate, ethyllinalool, eugenol, Evernia furfuracea extract, Evernia prunastri extract, farnesol, guaiac wood oil, hexyl cinnamal,

Hexyl salicylate, hydroxycitronellal, lavender oil, lemone oil, linayl acetate, tangerine oil, menthyl PCA, methyl heptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin.

According to the invention, the preparation according to the invention advantageously contains film formers. Film formers in the context of the present invention are substances of different composition, which are characterized by the following property: If a film former is dissolved in water or other suitable solvents and the solution is then applied to the skin, it forms according to

Evaporating the solvent a film, which essentially serves to fix the light filter on the skin and thus to increase the water resistance of the product.

It is particularly advantageous to use the film formers from the group of polymers based on polyvinylpyrrolidone (PVP).

to choose. Particularly preferred are copolymers of polyvinylpyrrolidone, for example, the PVP hexadecene copolymer and the PVP eicosene copolymer, which among the

Trade names Antaron V216 and Antaron V220 are available from the GAF Chemicals Cooperation.

Also advantageous are other polymeric film formers, such as sodium polystyrene sulfonate, sold under the tradename Flexan 130 at National Starch and Chemical Corp. is available, and / or polyisobutene, available from Rewo under the

Trade name Rewopal PIB1000. Other suitable polymers are e.g. Polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymers, polyglycols, acrylate / octylacralimide copolymer (Dermacryl 79), acrylates copolymer (Epitex 66). Also advantageous is the use of hydrogenated castor oil Dimerdilinoleat (CAS 646054-62-8, INCI Hydrogenated Castor Oil Dimer Dilinoleate), which can be purchased from Kokyu Alcohol Kogyo under the name Risocast DA-H or PPG-3 Benzylethermyristat ( CAS 403517-45-3), which can be obtained under the trade name Crodamol STS from Croda Chemicals.

According to the invention, the use of the preparation according to the invention for protection against skin aging (in particular for protection against UV-induced skin aging) and as

Sunscreens.

Examples

The following examples are intended to illustrate the present invention without limiting it. Unless indicated otherwise, all amounts, proportions and percentages are based on the weight and the total amount or on the total weight of the preparations. Emulsion 1

Emulsion 2

Total 100

Ethanolic sunscreen product

INCI Concentration (%)

Ethanol 60.08

Acrylates / Octylacrylamides Copolymer 1

Glycerol 5

1, 2-pentanediol 0.7

Menthol 0.17

Perfume 0.3

Compound 1 1

Homosalates 6.75

Octocrylene 7.5

Ethyl hexyl salicylates 4.5

Butyl Methoxydibenzoylmethane 3.5

C12-15 alkyl benzoates 9.5

Total 100

Claims

claims

1. Cosmetic preparation containing

a) one or more alkanediols selected from the group of compounds 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol, 2-methyl-1, 3-propanediol and

b)

Connection 1

2. Cosmetic preparation containing compound 1 in a concentration of 0.1 to 6% by weight, based on the total weight of the preparation.

3. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the total concentration of the alkanediols (1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol, 2-methyl-1, 3-propanediol) in the preparation of 0.1 to 5% by weight, based on the total weight of the preparation.

4. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation contains ethanol.

5. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains ethanol in a concentration of 0.1 to 99% by weight, based on the total weight of the preparation.

6. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains C12-C15 alkyl benzoate.

7. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains C12-C15 alkyl benzoate in a concentration of 1 to 20% by weight, based on the total weight of the preparation.

8. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more dialkyl adipates.

9. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more dialkyl carbonates.

10 Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, ß-alanine, panthenol, magnolol, honokiol,

Tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.

1 1. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains phenoxyethanol and / or ethylhexylglycerol.

12. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation contains one or more UV filters which are selected from the group of the compounds 2-phenylbenzimidazole-5-sulphonic acid and / or salts thereof; Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzenesulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methyl-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol ; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor; ethylhexyl salicylate;

Terephthalidendicamphersulfonsäure; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 2-ethylhexyl 4- (dimethylamino) benzoate; 4- (dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 2-ethylhexyl 4-methoxycinnamate; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone;

homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; 4- (tert-butyl) -4'-methoxydibenzoylmethane; 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoic acid hexyl ester; Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS no 288254-16-0); 2,4-Bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) ; 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) -tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino-] (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4,6-tribiphenyl-4-yl-1,3,5-triazine Merocyanines; titanium dioxide; zinc oxide.

13. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation is in the form of an emulsion.

14. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation is in the form of an O / W emulsion.

15. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate

(self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methylglycose distearate, sodium cetearylsulfate, sodium staroylglutamate, polyglyceryl-10-stearate, cetearyl alcohol,

Cetearylsulfosuccinate, potassium cetyl phosphate.